JCI - Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice

Go to JCI Insight

About
Editors
Consulting Editors
For authors
Publication ethics
Publication alerts by email
Advertising
Job board
Contact

100th anniversary
Current issue
Past issues
By specialty
Videos
- Conversations with Giants in Medicine
- Video Abstracts
Reviews
Viewpoint
Collections
Clinical Medicine

The Journal of Clinical Investigation
Current issue
Past issues
Specialties
Reviews
Review series
Videos
Conversations with Giants in Medicine
Video Abstracts
Collections
In-Press Preview
Clinical Medicine
Research Letters
Letters to the Editor
Editorials
Commentaries
Reviews
Viewpoints
Top read articles
Journal Details
About
Editors
Consulting Editors
For authors
Publication ethics
Publication alerts by email
Advertising
Job board
Contact

Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice

Chong Chen, … , Yang Liu, Pan Zheng

Chong Chen, … , Yang Liu, Pan Zheng

Published December 1, 2010
Citation Information: J Clin Invest. 2010;120(12):4583-4583. https://doi.org/10.1172/JCI43873C1.

View: Text | PDF | Amended Article

Corrigendum Inflammation

Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice

Text
PDF

Abstract

Authors

Chong Chen, Yu Liu, Yang Liu, Pan Zheng

×

Figure 4

Options: View larger image (or click on image) Download as PowerPoint

Copyright © 2024 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts